|
1
|
Schön MP and Boehncke WH: Psoriasis. N
Engl J Med. 352:1899–1912. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wei T, Xu N, Meisgen F, Ståhle M, Sonkoly
E and Pivarcsi A: Interleukin-8 is regulated by miR-203 at the
posttranscriptional level in primary human keratinocytes. Eur J
Dermatol. 19:2013.
|
|
3
|
Wolk K, Witte E, Wallace E, Döcke WD, Kunz
S, Asadullah K, Volk HD, Sterry W and Sabat R: IL-22 regulates the
expression of genes responsible for antimicrobial defense, cellular
differentiation, and mobility in keratinocytes: A potential role in
psoriasis. Eur J Immunol. 36:1309–1323. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Heidenreich R, Röcken M and Ghoreschi K:
Angiogenesis: The new potential target for the therapy of
psoriasis? Drug News Perspect. 21:97–105. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hongqin T, Xinyu L, Heng G, Lanfang X,
Yongfang W and Shasha S: Triptolide inhibits IFN-γ signaling via
the Jak/STAT pathway in HaCaT keratinocytes. Phytother Res.
25:1678–1685. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu Y, Xu X, Gao X, Chen H and Geng L:
Shikonin suppresses IL-17-induced VEGF expression via blockage of
JAK2/STAT3 pathway. Int Immunopharmacol. 19:327–333. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Koga C, Kabashima K, Shiraishi N,
Kobayashi M and Tokura Y: Possible pathogenic role of Th17 cells
for atopic dermatitis. J Invest Dermatol. 128:2625–2630. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Primo MN, Bak RO, Schibler B and Mikkelsen
JG: Regulation of pro-inflammatory cytokines TNFα and IL24 by
microRNA-203 in primary keratinocytes. Cytokine. 60:741–748. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cai Y, Fleming C and Yan J: New insights
of T cells in the pathogenesis of psoriasis. Cell Mol Immunol.
9:302–309. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nickoloff BJ and Wrone-Smith T: Animal
models of psoriasis. Nat Med. 3:475–476. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zamore PD and Haley B: Ribo-gnome: The big
world of small RNAs. Science. 309:1519–1524. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lerman G, Avivi C, Mardoukh C, Barzilai A,
Tessone A, Gradus B, Pavlotsky F, Barshack I, Polak-Charcon S,
Orenstein A, et al: MiRNA expression in psoriatic skin: Reciprocal
regulation of hsa-miR-99a and IGF-1R. PLoS One. 6:e209162011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pittelkow MR: Psoriasis: More than skin
deep. Nat Med. 11:17–18. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen CZ, Li L, Lodish HF and Bartel DP:
MicroRNAs modulate hematopoietic lineage differentiation. Science.
303:83–86. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Creamer D, Sullivan D, Bicknell R and
Barker J: Angiogenesis in psoriasis. Angiogenesis. 5:231–236. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huh JE, Baek YH, Lee MH, Choi DY, Park DS
and Lee JD: Bee venom inhibits tumor angiogenesis and metastasis by
inhibiting tyrosine phosphorylation of VEGFR-2 in LLC-tumor-bearing
mice. Cancer Lett. 292:98–110. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheng AM, Byrom MW, Shelton J and Ford LP:
Antisense inhibition of human miRNAs and indications for an
involvement of miRNA in cell growth and apoptosis. Nucleic Acids
Res. 33:1290–1297. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sonkoly E, Ståhle M and Pivarcsi A:
MicroRNAs: Novel regulators in skin inflammation. Clin Exp
Dermatol. 33:312–315. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cho A and Seok SH: Ethical guidelines for
use of experimental animals in biomedical research. J Bacteriol
Virol. 43:18–26. 2013. View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xiong H, Du W, Zhang YJ, Hong J, Su WY,
Tang JT, Wang YC, Lu R and Fang JY: Trichostatin A, a histone
deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing
the promoter-associated histone acetylation of SOCS1 and SOCS3 in
human colorectal cancer cells. Mol Carcinog. 51:174–184. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hueber W, Patel DD, Dryja T, Wright AM,
Koroleva I, Bruin G, Antoni C, Draelos Z, Gold MH; Psoriasis Study
Group, ; et al: Effects of AIN457, a fully human antibody to
interleukin-17A, on psoriasis, rheumatoid arthritis and uveitis.
Sci Transl Med. 2:52ra722010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zibert JR, Løvendorf MB, Litman T, Olsen
J, Kaczkowski B and Skov L: MicroRNAs and potential target
interactions in psoriasis. J Dermatol Sci. 58:177–185. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Darnell JE Jr: STATs and gene regulation.
Science. 277:1630–1635. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Valencia-Sanchez MA, Liu J, Hannon GJ and
Parker R: Control of translation and mRNA degradation by miRNAs and
siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Starnes T, Robertson MJ, Sledge G, Kelich
S, Nakshatri H, Broxmeyer HE and Hromas R: Cutting edge: IL-17F, a
novel cytokine selectively expressed in activated T cells and
monocytes, regulates angiogenesis and endothelial cell cytokine
production. J Immunol. 167:4137–4140. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Y, Zhou B, Zhang F, Wu J, Hu Y, Liu
Y and Zhai Q: Amyloid-β induces hepatic insulin resistance by
activating JAK2/STAT3/SOCS-1 signaling pathway. Diabetes.
61:1434–1443. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nickoloff BJ: Cracking the cytokine code
in psoriasis. Nat Med. 13:242–244. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Song B, Jin H, Yu X, Zhang Z, Yu H, Ye J,
Xu Y, Zhou T, Oudit GY, Ye JY, et al: Angiotensin-converting enzyme
2 attenuates oxidative stress and VSMC proliferation via the
JAK2/STAT3/SOCS3 and profilin-1/MAPK signaling pathways. Regul
Pept. 185:44–51. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zheng Y, Danilenko DM, Valdez P, Kasman I,
Eastham-Anderson J, Wu J and Ouyang W: Interleukin-22, a T(H)17
cytokine, mediates IL-23-induced dermal inflammation and
acanthosis. Nature. 445:648–651. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Krebs DL and Hilton DJ: SOCS:
Physiological suppressors of cytokine signaling. J Cell Sci.
113:2813–2819. 2000.PubMed/NCBI
|
|
33
|
Numasaki M, Fukushi J, Ono M, Narula SK,
Zavodny PJ, Kudo T, Robbins PD, Tahara H and Lotze MT:
Interleukin-17 promotes angiogenesis and tumor growth. Blood.
101:2620–2627. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liew SC, Das-Gupta E, Chakravarthi S, Wong
SF, Lee N, Safdar N and Jamil A: Differential expression of the
angiogenesis growth factors in psoriasis vulgaris. BMC Res Notes.
5:2012012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sankar L, Arumugam D, Boj S and Pradeep P:
Expression of angiogenic factors in psoriasis vulgaris. J Clin
Diagn Res. 11:EC23–EC27. 2017.PubMed/NCBI
|
